Pharmafile Logo
Pharmafocus logo
Advanced Search

HIV

Showing 15 posts of 200 posts found.

ViiV HIV drug boost

February 18, 2013
Sales and Marketing Dolutegravir, GSK, HIV, ViiV

ViiV Healthcare has received a boost with the news that the FDA is to give a priority review to its …

News

AbbVie splits from Abbott

January 7, 2013
Sales and Marketing AbbVie, Abbott, HIV, Humira

AbbVie, the new $18 billion biopharma company which includes many of Abbott’s most high profile products, has finally launched. Abbott …

News

Shionogi and ViiV strike new HIV deal

October 30, 2012
Research and Development, Sales and Marketing Atripla, Dolutegravir, HIV, Shionogi, ViiV

HIV specialist firm ViiV Healthcare has announced a new deal with Japan’s Shionogi on a promising new treatment. ViiV Healthcare …

News
BHIVA image

NHS under fire for ‘misdiagnosis’

October 5, 2012
Sales and Marketing BHIVA, HIV, NHS

Patients with HIV infections are going unnoticed by the NHS while those with rare diseases are often being misdiagnosed. These …

News

New quad HIV pill passed by FDA

September 2, 2012
Sales and Marketing FDA, Gilead, HIV, stribild

Gilead’s four-in-one anti-HIV once-daily pill Stribild has been given the green light by the FDA for adults who have not …

News

Pharma R&D model no help to developing countries

May 22, 2012
Research and Development, Sales and Marketing HIV, MSF, Médecins Sans Frontières, R&D

Médecins Sans Frontières is urging health ministers around the world to create an ‘R&D Convention’ to ensure that pharma helps …

News

New Quad HIV pill on track for FDA approval

May 14, 2012
Research and Development, Sales and Marketing BMS, Compera, FDA, Gilead, HIV, The Quad

Gilead Sciences’ four-in-one HIV pill has been given the thumbs up by an FDA advisory group.  The US regulator is …

News
Novartis image

Novartis Indian patent battle nears conclusion

March 7, 2012
Sales and Marketing Glivec, HIV, India, Novartis, patents

A long-running battle over the patent of cancer treatment Glivec in India is about to reach its dramatic climax.India’s Supreme …

News
Lonza picture

Lonza forges joint venture with South Africa for HIV drugs

February 13, 2012
Manufacturing and Production HIV, Lonza, South Africa

Swiss contract manufacturer Lonza has signed a joint venture agreement with the government of South Africa that could significantly reduce …

News

Doctors decry cost-cutting in HIV treatment

November 2, 2011
Sales and Marketing HIV, NHS, Reyataz

Doctors in London are opposing a decision to switch HIV patients to a cheaper drug, saying it could harm patients. …

News
Boehringer

Boehringer signs away HIV rights to focus on hep C

October 7, 2011
Research and Development Boehringer, Gilead, HIV, hepatitis C

Boehringer Ingelheim has signed a deal giving Gilead Sciences exclusive worldwide rights to a major part of its HIV portfolio. …

News

Triple regimen HIV pill gains approval

August 11, 2011
Gilead, HIV, J&J, JJ, Truvada

A new three-in-one pill Complera has been approved in the US as a first line treatment for HIV. Complera combines …

News

Once daily Viramune set for approval in Europe

August 1, 2011
Sales and Marketing Boehringer Ingelheim, HIV

European regulators have recommended the approval of a new, once-daily form of Boehringer Ingelheim’s HIV treatment Viramune. Viramune (nevirapine) has …

News

HIV drug Prezista recalled on TBA contamination

May 17, 2011
Manufacturing and Production HIV, Johnson & Johnson, Prezista, manufacturing and production, recalls

Johnson & Johnson has recalled 11,700 bottles of its HIV treatment Prezista after consumer reports of a mouldy smell caused …

News

BMS licences phase II HIV compound festinavir

December 22, 2010
Research and Development BMS, Bristol-Myers Squibb, HIV, NRTI, Oncolys BioPharma, festinavir, nucleoside reverse transcriptase inhibitor

Bristol-Myers Squibb is to pay hundreds of millions of dollars to a Japanese biotech firm to get its hands on …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025